Physician profile
Harrison Plunkett
NPI 1649682774
$3,313.58
in general payments reported to CMS, 2019-2025
9 companies · $550 in 2025
The $550 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $776 · 2023: $1,134 · 2024: $853 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,519 · Travel and Lodging: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.36 |
| Travel and Lodging | $1,017.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,258.96 | 2022-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $641.24 | 2023-2025 | Eterna, Octrode, Proclaim |
| Nalu Medical, INC. | $484.03 | 2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $430.79 | 2022-2023 | Vanta Adaptivestim |
| Mml US, INC. | $340.98 | 2022 | |
| Spr Therapeutics, INC | $81.25 | 2023 | Sprint Pns System |
| Vertos Medical, INC. | $35.00 | 2023-2024 | Mild Device Kit |
| Stryker Corporation | $22.06 | 2023 | Spinejack |
| Curonix LLC | $19.27 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Plunkett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.